A new Relentless Health Value podcast features expert opinions on digital medicine solutions, as well as their key takeaways from the recent NODE.Health Digital Medicine Conference which was hosted in December. Guests include: Digital Therapeutics Alliance Executive Director Megan […]
NorthShore, Color Partner to Implement Genomic Data for 10K Patients
NorthShore University HealthSystem and Color are joining forces to introduce genomic data into the decision-making process for more than 10,000 patients, HealthITAnalytics reports. According to the report, the DNA10K effort will combine genomics with electronic health records to uncover any […]
Survey Finds Hospitals with Value-Based Models Investing More in Population Health Tools
A recent survey by Deloitte suggests that hospitals that have take up value-based care models are ramping up investments in health information technology to bolster population health management, data analytics and care coordination. The researchers, according to a HealthITAnalytics report, also say […]
HealthCore-NERI’s Singer Talks RWE, Pragmatic Clinical Trials
HealthEconomics.Com Founder and CEO Dr. Patti Peeples recently discussed with HealthCore-NERI CMO Dr. Joseph Singer the impact of pragmatic clinical trials on real-world evidence (RWE). HealthCore-NERI works with a range of stakeholders to deliver RWE to support a number of health care […]
Special Issue of AJMC Spotlights Health IT
A special edition of the American Journal of Managed Care (AJMC) shifts the spotlight to health care information technology, bringing features from experts on electronic health records, interoperability and patient-facing technology. Included in the January issue are articles on the tools necessary […]
United Healthcare Sues Pharma Companies
Citing a conspiracy to "fix, increase, stabilize, or maintain prices of generic drugs," United Healthcare Services (UHS) has filed a lawsuit against a host of drugmakers alleging they violated antitrust laws, Bloomberg Law reports. UHS in its lawsuit demands that the companies put any […]
Lack of Standardized Definition of Value Detrimental to Push, Article Says
Bringing about a standardized definition of value is key to pushing forward health technology assessments in the 21st century, a recent opinion piece on Morning Consult states. Three key questions that must be answered, the author states, are: What is value-based health care? Why is it so […]
Despite Much Health Care Data, Obstacles Complicate Their Use
U.S. regulations on health care data are stymieing the potential of data garnered through electronic health records, a recent study in the Journal of the American Medical Informatics Association suggests. The study, according to a FierceHealthcare report, suggests regulations have yet to encompass […]
Opinion: U.S. Shouldn’t Outsource Drug Value Assessments Through an IPI
A recent opinion article published on STAT says the U.S. should conduct in-house value assessments for prescription drugs rather than look to other countries' prices as proposed by President Donald Trump's administration. The administration last year proposed an international pricing index as a way […]
Report: Medicare Part D Could Have Saved $14.4 Billion in 2016 by Negotiating to VA Prices
A recent analysis found that the government could have saved roughly $14 billion on the top 50 drugs covered by Medicare Part D in 2016 if the program negotiated drugmakers down to prices paid by the Department of Veterans Affairs, STAT reports. Part D, according to the report, could have saved […]
ISPOR Offering Members Webinar on Statistical Learning
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is offering a web event to its members on statistical learning, and how it fits into a health care landscape in which artificial intelligence and machine learning are becoming prominent themes. The webinar, which is […]
CMS Proposal Seeks Comments on ‘Silver Loading’
The Centers for Medicare and Medicaid Services (CMS) is asking for feedback in its latest Notice of Benefit and Payment Parameters about how it could best handle "silver loading" by Affordable Care Act (ACA) plans, according to a FierceHealthcare report. Insurance plans after the elimination of […]
How Will the Shutdown Affect FDA Operations?
The ongoing government shutdown could have already had an impact on the Food and Drug Administration's decision-making abilities, with some experts saying new, innovative drugs could be delayed, pharmaphorum reports. "In a very grim view of this, there are lives that are going to be lost because […]
Article Analyzes Characteristics, Spending Patterns of High-Cost Medicare Patients
A recent article published in Health Affairs found that 28 percent of high-cost Medicare beneficiaries in 2012 remained high-cost over the two following years, and that most were younger and more likely to be minorities. The article by Harvard Medical School's Jose F. Figueroa et al. focused on a […]
ICER Plans New Annual Report on Price Increases
The Institute for Clinical and Economic Review (ICER) this week released a report outlining a new annual review which will look to determine whether significant price increases on prescription drugs are supported by clinical evidence. The "Unsupported Price Increase" report remains in the planning […]
Pharmerit Expands Market Access Support in Asia
Pharmerit International (Pharmerit), a leading health economics and outcomes research (HEOR) consultancy, is expanding its Asian presence. The expansion includes the growth of the Shanghai, China, office as well as establishment of an office in Mumbai, India. The Asia-Pacific region is a rapidly […]
Study: Moving Some Plans to Part D Could Cut Spending, but Not for Some Patients
While a proposal to move some Medicare Part B plans to Part D could reduce overall drug spending, a recent study found that some patients could face higher out-of-pocket costs, Reuters reports. The Trump administration's proposal aims to reduce spending by giving plans the ability to negotiate drug […]
ICMJE Updates Reporting Recommendations
The International Committee of Medical Journal Editors (ICMJE) is addressing a number of issues in medical publishing with recent updates to its "Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals." According to a Publication Plan report, […]
Coalition Launches Ad Campaign Against Trump’s Medicare Proposal
The American Cancer Society's advocacy branch is leading the charge alongside patient advocacy and medical groups in an advertising campaign against a Medicare change proposed by President Donald Trump's administration, according to STAT report. The coalition, which includes the American Medical […]
New Non-Profit Association Launches Free Guideline Clearinghouse for Healthcare Providers
A new non-profit association, the Alliance for the Implementation of Clinical Practice Guidelines (AiCPG), announced the launch of a new guideline clearinghouse that fills the gap left by the defunded Agency for Healthcare Research and Quality’s (AHRQ) National Guideline Clearinghouse […]
PhRMA: Report Shows How IPI Model Would Negatively Impact Access
PhRMA says a new report released by IHS Markit backs a belief by some groups that the international pricing index for Medicare Part B drugs proposed by the Department of Health and Human Services would negatively impact patient access. "One of the most common concerns is that patients in the United […]
CMS Administrator Stresses Importance of Hospital Price Transparency
Centers for Medicare and Medicaid Services Administrator Seema Verma recently reiterated during a media call the importance of transparent hospital prices in connection with the pricing mandate that went into effect Jan. 1. According to a RevCycleIntelligence report, Verma said informed consumers […]
New Documents in Lawsuit Reveal OxyContin Marketing Strategy by Purdue
Recently-released documents in a lawsuit against Purdue reveal how the drugmaker marketed OxyContin, according to a STAT report. Dr. Richard Sackler, who is a member of the family that controls Purdue, during a launch party for the drug in 1996 said the release of OxyContin would "be followed by a […]
Cummings: Current Rate of Price Increases ‘Unsustainable’
U.S. House Oversight Committee Chairman Elijah Cummings says research and development by major pharmaceutical companies has paved the way for "groundbreaking medications," but called the current rate of price increases "unsustainable," according to an Associated Press report. Cummings, a Democrat, […]
House Dems Launch Drug Pricing Investigation
The U.S. House Oversight Committee announced Monday it is investigating the drug pricing practices of a dozen pharmaceutical companies, CNBC reports. Committee chairman Elijah Cummings sent letters to the following drugmakers, according to the report: AbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, […]
Register Now for Upcoming Webinar on HEOR, RWE Strategies and Best Practices!
Join industry experts Julie Carter, Category Director of RWE & HEOR, Scientist.com, Patti Peeples, RPh, PhD, CEO and Founder of HealthEconomics.com and Principal Researcher at HE Institute and Mary Beth Ritchey, PhD, Director of Epidemiology for Medical Devices at RTI Health Solutions for a live […]
Program Looks to Spur Discussion on IBD Treatment Decision-Making
An upcoming program offered by PRIME Education and the Academy of Managed Care Pharmacy (AMCP) aims to facilitate discussions between payers and providers on IBD treatment decision-making. The program, titled "Payer and Provider Workshops: Advancing Collaborative Approaches in IBD Treatment […]
Health Partners Plans’ Donovan: We’re Nearing Tipping Point in Value-Based Purchasing
Health Partners Plan Network Management Vice President Brian Donovan tells RevCycleIntelligence believes we're nearing a tipping point in value-based purchasing. Donovan says despite "relatively low" adoption rates across the country, "almost all health plans and providers are doing work in this […]
CMS’ Verma Tells Hospitals to be Proactive on Cost Transparency
Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma is urging hospitals to take proactive measures to bolster transparency on health care prices following concerns about whether chargemasters were creating more confusion among patients, RevCycleIntelligence reports. The […]
High Cost of Insulin Can Prove Deadly for Some
Skyrocketing insulin costs have created a heavy burden on some patients, especially the uninsured and underinsured, with some even rationing the life-saving medication to help dampen the blow on their wallets, the Washington Post reports. Citing data from IBM Watson Health, the Washington Post […]
